Molecules · 10 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This preclinical study isolated an anthraquinone-flavonoid complex from Rumex tianschanicus roots and tested its antiulcer activity in a rat model of indomethacin-induced gastric ulcers. The complex, when administered prophylactically or for a prolonged period, demonstrated antiulcer activity, with histological evidence of mucosal healing. The main limitation is that this is an animal study; its efficacy and safety in humans remain unknown.
Peptic ulcer disease is a significant global health issue, and herbal medicines are sought as safer alternatives to conventional drugs. The Kazakh plant Rumex tianschanicus is used in folk medicine but lacks scientific evaluation for antiulcer activity. Methods: Researchers isolated a polyphenolic anthraquinone–flavonoid complex (AFC) from the plant's roots, identifying six compounds (physcion, chrysophanol, emodin, isorhamnetin, quercetin, myricetin). The AFC's antiulcer activity was tested in Wistar rats using an indomethacin-induced gastric ulcer model. Five groups were studied: a control, an untreated ulcer group, and three AFC treatment groups (prophylactic, single-dose, and 10-day prolonged administration at 100 mg/kg). Outcomes included body/organ weights, ulcer prevalence, ulcer counts, Paul's Index, antiulcer activity index, and histopathology. Key Results: The untreated ulcer group showed significant weight loss and reduced liver/stomach mass. Prophylactic and prolonged AFC administration significantly increased body weight and organ masses. The AFC reduced ulcer prevalence (from 92% in the ulcer group to 60% and 30% for prophylactic and prolonged groups, respectively) and the number of punctate and large ulcers. The antiulcer activity index was >2.0 for these groups, indicating positive activity. Histology showed that AFC treatment promoted mucosal healing, with complete epithelialization observed in the prolonged-use group. A single AFC dose had no significant effect. Limitations: This is an animal model study, and the findings do not directly translate to human therapy. The study did not include a positive control drug for comparison. Implications: The AFC from R. tianschanicus shows promise as a potential antiulcer agent in this preclinical model, warranting further research into its mechanisms and safety profile.
